Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
2.640
+0.060 (2.33%)
At close: Nov 7, 2025, 4:00 PM EST
2.630
-0.010 (-0.38%)
After-hours: Nov 7, 2025, 4:10 PM EST
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $13.66 million as of November 7, 2025. Its market cap has decreased by -52.50% in one year.
Market Cap
13.66M
Enterprise Value
4.29M
1-Year Change
-52.50%
Ranking
Category
Stock Price
$2.64
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $13.66M, a decrease of -97.84%. That is a compound annual growth rate of -56.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 13.66M | -59.99% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 840.40B |
| Johnson & Johnson | 450.08B |
| AbbVie | 385.61B |
| UnitedHealth Group | 292.81B |
| AstraZeneca | 251.76B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.32B |
| Merck & Co. | 212.86B |